Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021

India's Bharat Biotech is aiming to have a production capacity of about 700 million doses of its COVID-19 vaccine this year, according to a top executive of the biotechnology company.

The vaccine candidate, COVAXIN, received emergency use approval from India's drugs regulator on Sunday, a move that faced questions from industry experts and opposition lawmakers due to lack of efficacy data. Efficacy data from the company's ongoing late-stage trial should be available by March, Krishna Ella, chairman and managing director.....

This article is no longer available in our repository.

There could be multiple reasons for this.